Services

High-density Protein Microarray
 
Autoimmune diseases are conditions caused by the immune system's immune response to components of the body itself, resulting in damage. These diseases can affect multiple systems and organs throughout the body, with over a hundred different types. The overall incidence rate of autoimmune diseases globally is approximately 10%. The broad-spectrum autoantibody detection chip covers more than 4000 autoantibody indicators with clinical guidance value, as well as corresponding positive and negative controls. It can be widely used for high-throughput detection of autoantibodies in the body fluids of patients with 25 common autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and autoimmune hepatitis. This chip is capable of detecting multiple antibody subtypes, including IgM, IgG, IgG1-4, IgA, and IgA1-2.

Technical Principles

Two-step detection method:
Firstly, multiple disease-related antigens are immobilized on a glass substrate. These antigens then bind with the corresponding specific antibodies or antigens present in the sample to be tested. Subsequently, fluorescently labeled antibodies or antigens are added. Finally, the fluorescent signals are detected. Using scientific algorithms developed for image processing and pattern recognition, the analysis is conducted to enable the detection of specific autoantibodies.

Technical Advantages

  • High-throughput
    4000+ autoantigens
  • Short Detection Time
    1-2 hours
  • High-sensitivity
    66.7 aM

    High Reproducibility with R of 0.97-0.99
  • Custome need

    Low Sample Consumption
    1-10 µL clinical sample

Application Areas

  • Biomarker Discovery
  • Desease Diagnostics
  • Autoantibody Profiling 
  • Protein-Protein Interaction 
  • Drug Target Identification
  • Antibody Specificity and Cross-reaction

References

  • [1]Jaycox JR, Dai Y, Ring AM. Decoding the autoantibody reactome. Science. 2024 Feb 16;383(6684):705-707. doi: 10.1126/science.abn1034. Epub 2024 Feb 15. PMID: 38359108.阅读全文
  • [2]Macdonald IK, Parsy-Kowalska CB, Chapman CJ. Autoantibodies: Opportunities for Early Cancer Detection. Trends Cancer. 2017 Mar;3(3):198-213. doi: 10.1016/j.trecan.2017.02.003. Epub 2017 Mar 6. PMID: 28718432.阅读全文
  • [3]Hershko AY, Naparstek Y. Autoimmunity in the era of genomics and proteomics. Autoimmun Rev. 2006 Apr;5(4):230-3. doi: 10.1016/j.autrev.2005.07.003. Epub 2005 Aug 8. PMID: 16697962.阅读全文
  • [4]Kobayashi M, Katayama H, Fahrmann JF, Hanash SM. Development of autoantibody signatures for common cancers. Semin Immunol. 2020 Feb;47:101388. doi: 10.1016/j.smim.2020.101388. Epub 2020 Jan 8. PMID: 31924500.阅读全文